Found 7 matching trials
Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease PHASE3 The primary objective of this study is to provide continued access to levod...
Show More Location
University of Alabama at Birmingham /ID# 49941
Learn More & Join Trial
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects PHASE3 The primary objective of this study was to demonstrate the superiority of l...
Show More Location
Site Reference ID/Investigator# 45719
Learn More & Join Trial
Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact PHASE4 The primary objective of this study is to collect health economic data depi...
Show More Location
Multiple Locations
Learn More & Join Trial
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease PHASE3 The primary objective of this study will be to provide further evidence of ...
Show More Location
Site Reference ID/Investigator# 50065
Learn More & Join Trial
Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects PHASE3 Long term safety and efficacy (12 months) of levodopa-carbidopa intestinal ...
Show More Location
Site Reference ID/Investigator# 45869
Learn More & Join Trial
A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications PHASE3 The primary objective of this study is to measure the efficacy of ABT-SLV18...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects PHASE3 The primary objective of this study was to demonstrate the superiority of l...
Show More Location
Site Reference ID/Investigator# 45931
Learn More & Join Trial